These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 26306035)

  • 41. F-box and WD repeat domain-containing-7 (Fbxw7) protein targets endoplasmic reticulum-anchored osteogenic and chondrogenic transcriptional factors for degradation.
    Yumimoto K; Matsumoto M; Onoyama I; Imaizumi K; Nakayama KI
    J Biol Chem; 2013 Oct; 288(40):28488-502. PubMed ID: 23955342
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The canonical wnt signal restricts the glycogen synthase kinase 3/fbw7-dependent ubiquitination and degradation of eya1 phosphatase.
    Sun Y; Li X
    Mol Cell Biol; 2014 Jul; 34(13):2409-17. PubMed ID: 24752894
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Proteomic screen reveals Fbw7 as a modulator of the NF-κB pathway.
    Arabi A; Ullah K; Branca RM; Johansson J; Bandarra D; Haneklaus M; Fu J; Ariës I; Nilsson P; Den Boer ML; Pokrovskaja K; Grandér D; Xiao G; Rocha S; Lehtiö J; Sangfelt O
    Nat Commun; 2012; 3():976. PubMed ID: 22864569
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Novel mechanism by which histone deacetylase inhibitors facilitate topoisomerase IIα degradation in hepatocellular carcinoma cells.
    Chen MC; Chen CH; Chuang HC; Kulp SK; Teng CM; Chen CS
    Hepatology; 2011 Jan; 53(1):148-59. PubMed ID: 21254166
    [TBL] [Abstract][Full Text] [Related]  

  • 45. BCL-3 degradation involves its polyubiquitination through a FBW7-independent pathway and its binding to the proteasome subunit PSMB1.
    Keutgens A; Zhang X; Shostak K; Robert I; Olivier S; Vanderplasschen A; Chapelle JP; Viatour P; Merville MP; Bex F; Gothot A; Chariot A
    J Biol Chem; 2010 Aug; 285(33):25831-40. PubMed ID: 20558726
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The E3 ubiquitin ligases β-TrCP and FBXW7 cooperatively mediates GSK3-dependent Mcl-1 degradation induced by the Akt inhibitor API-1, resulting in apoptosis.
    Ren H; Koo J; Guan B; Yue P; Deng X; Chen M; Khuri FR; Sun SY
    Mol Cancer; 2013 Nov; 12():146. PubMed ID: 24261825
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The glomuvenous malformation protein Glomulin binds Rbx1 and regulates cullin RING ligase-mediated turnover of Fbw7.
    Tron AE; Arai T; Duda DM; Kuwabara H; Olszewski JL; Fujiwara Y; Bahamon BN; Signoretti S; Schulman BA; DeCaprio JA
    Mol Cell; 2012 Apr; 46(1):67-78. PubMed ID: 22405651
    [TBL] [Abstract][Full Text] [Related]  

  • 48. FBW7 Inhibits Myeloid Differentiation in Acute Myeloid Leukemia via GSK3-Dependent Ubiquitination of PU.1.
    Mishra M; Thacker G; Sharma A; Singh AK; Upadhyay V; Sanyal S; Verma SP; Tripathi AK; Bhatt MLB; Trivedi AK
    Mol Cancer Res; 2021 Feb; 19(2):261-273. PubMed ID: 33188146
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The SCF-FBW7β E3 ligase mediates ubiquitination and degradation of the serine/threonine protein kinase PINK1.
    Jeon SJ; Chung KC
    J Biol Chem; 2024 Apr; 300(4):107198. PubMed ID: 38508312
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fbw7α and Fbw7γ collaborate to shuttle cyclin E1 into the nucleolus for multiubiquitylation.
    Bhaskaran N; van Drogen F; Ng HF; Kumar R; Ekholm-Reed S; Peter M; Sangfelt O; Reed SI
    Mol Cell Biol; 2013 Jan; 33(1):85-97. PubMed ID: 23109421
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ras activity regulates cyclin E degradation by the Fbw7 pathway.
    Minella AC; Welcker M; Clurman BE
    Proc Natl Acad Sci U S A; 2005 Jul; 102(27):9649-54. PubMed ID: 15980150
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fbxw7 acts as an E3 ubiquitin ligase that targets c-Myb for nemo-like kinase (NLK)-induced degradation.
    Kanei-Ishii C; Nomura T; Takagi T; Watanabe N; Nakayama KI; Ishii S
    J Biol Chem; 2008 Nov; 283(45):30540-8. PubMed ID: 18765672
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Multisite phosphorylation by Cdk2 and GSK3 controls cyclin E degradation.
    Welcker M; Singer J; Loeb KR; Grim J; Bloecher A; Gurien-West M; Clurman BE; Roberts JM
    Mol Cell; 2003 Aug; 12(2):381-92. PubMed ID: 14536078
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A new mechanism of RhoA ubiquitination and degradation: roles of SCF(FBXL19) E3 ligase and Erk2.
    Wei J; Mialki RK; Dong S; Khoo A; Mallampalli RK; Zhao Y; Zhao J
    Biochim Biophys Acta; 2013 Dec; 1833(12):2757-2764. PubMed ID: 23871831
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Thiazolidinediones modulate the expression of beta-catenin and other cell-cycle regulatory proteins by targeting the F-box proteins of Skp1-Cul1-F-box protein E3 ubiquitin ligase independently of peroxisome proliferator-activated receptor gamma.
    Wei S; Lin LF; Yang CC; Wang YC; Chang GD; Chen H; Chen CS
    Mol Pharmacol; 2007 Sep; 72(3):725-33. PubMed ID: 17569795
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The SCF-type E3 Ubiquitin Ligases as Cancer Targets.
    Kitagawa K; Kitagawa M
    Curr Cancer Drug Targets; 2016; 16(2):119-29. PubMed ID: 26560120
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of SKP1-CUL1-F-box-protein (SCF) E3 ubiquitin ligases in skin cancer.
    Xie CM; Wei W; Sun Y
    J Genet Genomics; 2013 Mar; 40(3):97-106. PubMed ID: 23522382
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Structure of a Fbw7-Skp1-cyclin E complex: multisite-phosphorylated substrate recognition by SCF ubiquitin ligases.
    Hao B; Oehlmann S; Sowa ME; Harper JW; Pavletich NP
    Mol Cell; 2007 Apr; 26(1):131-43. PubMed ID: 17434132
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dual regulation of Fbw7 function and oncogenic transformation by Usp28.
    Schülein-Völk C; Wolf E; Zhu J; Xu W; Taranets L; Hellmann A; Jänicke LA; Diefenbacher ME; Behrens A; Eilers M; Popov N
    Cell Rep; 2014 Nov; 9(3):1099-109. PubMed ID: 25437563
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MiRNA-27a controls FBW7/hCDC4-dependent cyclin E degradation and cell cycle progression.
    Lerner M; Lundgren J; Akhoondi S; Jahn A; Ng HF; Akbari Moqadam F; Oude Vrielink JA; Agami R; Den Boer ML; Grandér D; Sangfelt O
    Cell Cycle; 2011 Jul; 10(13):2172-83. PubMed ID: 21597324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.